OMNIQ Corp. (OMQS): Nasdaq/NYSE listing notice — OmniQ receives Nasdaq delisting notice for failure to meet minimum market value; intends to appeal

OMNIQ Corp.

August 9, 2023 notice: MVLS below $35M minimum for 30 consecutive days; given 180 days until Feb 5, 2024 to regain compliance.
February 8, 2024 notice: Company has not regained compliance; suspension set for Feb 20, 2024 unless appeal is filed.
Company intends to appeal to Hearings Panel by Feb 15 deadline and has paid $20,000 hearing fee.
Appeal will stay suspension pending Hearings Panel decision; delisting risk remains.
Ticker: OMQS; common stock currently listed on Nasdaq.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

OMNIQ Corp. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2), 5810(c)(3)(C)

Exact text from the filing

February 8, 2024, the Company received a new notice (the “Notice”) from the Staff that the Company has not regained compliance with Nasdaq Listing Rule 5550(b)(2), and thus, unless the Company requests an appeal of this determination from the Staff, the Company’s common stock will be suspended at the opening of business on February 20, 2024, which will remove the Company’s securities from listing and registration on Nasdaq. As of the date of this current report on Form 8-K, and in accordance with the Nasdaq Listing Rule 5800 Series, the Company may appeal the Staff’s determination to the heari

View on SEC.gov

Browse all listing & compliance notices →

OMNIQ Corp. filing history →

Source: SEC EDGAR

accession 0001493152-24-006698

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.